These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU). Gerris J; De Vits A; Joostens M; Van Royen E Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071 [TBL] [Abstract][Full Text] [Related]
3. Ovulation induction with gonadotropins in women with polycystic ovary disease. Kupferminc MJ; Lessing JB; Peyser MR J Reprod Med; 1991 Jan; 36(1):61-4. PubMed ID: 1901089 [TBL] [Abstract][Full Text] [Related]
4. Management of overstimulated gonadotrophin cycles with a controlled drift period. Urman B; Pride SM; Yuen BH Hum Reprod; 1992 Feb; 7(2):213-7. PubMed ID: 1577933 [TBL] [Abstract][Full Text] [Related]
6. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction. Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938 [TBL] [Abstract][Full Text] [Related]
7. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation. Lee KL; Couchman GM; Walmer DK J Assist Reprod Genet; 2005 Jan; 22(1):37-40. PubMed ID: 15807221 [TBL] [Abstract][Full Text] [Related]
8. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Blankstein J; Shalev J; Saadon T; Kukia EE; Rabinovici J; Pariente C; Lunenfeld B; Serr DM; Mashiach S Fertil Steril; 1987 Apr; 47(4):597-602. PubMed ID: 3106098 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis-specific serum 17 beta-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay. Haning RV; Boehnlein LM; Carlson IH; Kuzma DL; Zweibel WJ Fertil Steril; 1984 Dec; 42(6):882-9. PubMed ID: 6437878 [TBL] [Abstract][Full Text] [Related]
10. Preovulatory luteinization during induction of follicular maturation with menotrophin and menotrophin--clomiphene combination. Birkenfeld A; Mor-Joseph S; Ezra J; Simon A; Navot D Hum Reprod; 1990 Jul; 5(5):561-4. PubMed ID: 2118544 [TBL] [Abstract][Full Text] [Related]
11. The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries. Prelevic GM; Ginsburg J; Maletic D; Hardiman P; Okolo S; Balint-Peric L; Thomas M; Orskov H Hum Reprod; 1995 Jan; 10(1):28-32. PubMed ID: 7745065 [TBL] [Abstract][Full Text] [Related]
12. [Gonadotrophin induction of ovulation monitored by ultrasonic studies of the ovary]. van Schouwenburg JA S Afr Med J; 1985 May; 67(19):754-8. PubMed ID: 3922064 [TBL] [Abstract][Full Text] [Related]
13. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy. Notation AD; Tagatz GE; Steffes MW Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235 [TBL] [Abstract][Full Text] [Related]
14. Ultrasonic assessment of subsequent unexplained infertility after ovulation induction. Coulam CB; Hill LM; Breckle R Br J Obstet Gynaecol; 1983 May; 90(5):460-7. PubMed ID: 6405780 [TBL] [Abstract][Full Text] [Related]
15. Follicular size at the time of human chorionic gonadotropin administration predicts ovulation outcome in human menopausal gonadotropin-stimulated cycles. Silverberg KM; Olive DL; Burns WN; Johnson JV; Groff TR; Schenken RS Fertil Steril; 1991 Aug; 56(2):296-300. PubMed ID: 1906408 [TBL] [Abstract][Full Text] [Related]
16. Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate: menotropin therapy for induction of ovulation. Tal J; Paz B; Samberg I; Lazarov N; Sharf M Fertil Steril; 1985 Sep; 44(3):342-9. PubMed ID: 3928406 [TBL] [Abstract][Full Text] [Related]
17. Induction of ovulation with combined human gonadotropins and dexamethasone in women with polycystic ovarian disease. Evron S; Navot D; Laufer N; Diamant YZ Fertil Steril; 1983 Aug; 40(2):183-6. PubMed ID: 6409672 [TBL] [Abstract][Full Text] [Related]
18. Management of gonadotrophin-induced cycles characterized by a significant discrepancy between oestrogen levels and dominant follicle size. Ben-Nun I; Gruber A; Abramowicz J; Fejgin M; Ben-Aderet N Hum Reprod; 1986 Sep; 1(6):365-8. PubMed ID: 3104400 [TBL] [Abstract][Full Text] [Related]